jurnalul român de psihofarmacologie romanian journal of ...
jurnalul român de psihofarmacologie romanian journal of ...
jurnalul român de psihofarmacologie romanian journal of ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
106. Caine ED, Polinsky RJ, Kartzinel R, Ebert, MH. The trial use <strong>of</strong> clozapine for abnormal<br />
involuntary movement disor<strong>de</strong>r. Am J Psychiatry 1979; 136:317-320.<br />
107. Van Vugt JP, Siesling S, Vergeer M, van <strong>de</strong>r Vel<strong>de</strong> EA, Roos RA. Clozapine versus<br />
placebo in Huntington’s disease: A double-blind randomized comparative study. J Neurol<br />
Neurosurg Psychiatry 1997; 63:35-59.<br />
108. The French Clozapine Parkinson Study Group. Clozapine in drug-induced psychosis in<br />
Parkinson’s disease. Lancet 1999; 353:2041-2042.<br />
109. The Parkinson Study Group. Low-dose clozapine for the treatment <strong>of</strong> drug-induced<br />
psychosis in Parkinson’s disease. N Eng J Med 1999; 340:787-793.<br />
110. Goetz CG, Blasucci LM, Leurgans S, Pappert GJ. Olanzapine and clozapine: comparative<br />
effects on motor function in hallucinating PD patients. Neurology 26 2000; 55:789-794.<br />
111. Ellis T, Cudokowicz ME, Sexton PM, Grow<strong>de</strong>n JH. Clozapine and risperidone treatment <strong>of</strong><br />
psychosis in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 2000; 12:364-369.<br />
112. Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. Clozapine-induced<br />
agranulocytosis: inci<strong>de</strong>nce and risk factors in the United States. N Engl J Med 1993;<br />
329:162-167.<br />
113. Idanpaan-Heikkila J, Alhava E, Olkinoura M, Polva IP. Agranulocytosis during treatment<br />
with clozapine. Eur J Clin Pharmacol 1977; 11:193-198.<br />
114. Hummer M, Kurz M, Barnas C, Aria A, Fleischhacker WW. Clozapine-induced transient<br />
white blood count disor<strong>de</strong>rs. J Clin Psychiatry 1994; 55:429-432.<br />
115. Wilson WH, Claussen AM. Seizures associated with clozapine treatment in a state hospital.<br />
J Clin Psychiatry 1994; 55:184-188.<br />
116. Dev F, Krupp P. The si<strong>de</strong>-effects and safety <strong>of</strong> clozapine. Rev Contemp Pharmacother<br />
1995; 6:197-208.<br />
117. Young CR, Bowers MD, Mazure CM. Management <strong>of</strong> the adverse effects <strong>of</strong> clozapine.<br />
Schizophr Bull 1998; 24:381-390.<br />
118. Miller DD. Review and management <strong>of</strong> clozapine si<strong>de</strong>-effects. J Clin Psychiatry 2000;<br />
61(suppl. 8):14-17.<br />
119. Beasley Jr CM, Sanger TM, Satterlee W, Tollefson, G, Tran P, Hamilton S, Olanzapine<br />
HGAD Study Group. Olanzapine versus placebo: results <strong>of</strong> a double-blind, fixed-dose<br />
olanzapine trial. Psychopharmacology 1996; 124:159-160.<br />
120. Beasley Jr CM, Tollefson G, Tran PV, Satterlee W, Sanger T, Hamilton S, Olanzapine<br />
HGAD Study Group. Olanzapine versus placebo and haloperidol: acute phase results <strong>of</strong> the<br />
North American double-blind olanzapine trial. Neuropsychopharmacol 1996; 14:11-23.<br />
141
Change language